Regeneron's Antibody Cocktail Helps Prevent Symptomatic COVID Infections | Talk Radio 105.9 : vimarsana.com

Regeneron's Antibody Cocktail Helps Prevent Symptomatic COVID Infections | Talk Radio 105.9


By Bill Galluccio
Apr 12, 2021
Regeneron announced that the results of a Phase 3 clinical trial show that its antibody cocktail helps prevent symptomatic COVID-19 infections. The company said that the drug, named REGEN-COV, reduced the risk of symptomatic infections by 81%.
The drug cocktail was granted an emergency use authorization by the Food and Drug Administration to treat high-risk, non-hospitalized patients with mild to moderate symptoms of COVID-19. That treatment was only approved to be given intravenously.
"COVID-19 transmission often occurs via infected people who do not yet have symptoms, so it is critical that we rapidly diagnose and treat these individuals for their own health and to prevent transmission," said 

Related Keywords

United States , , Drug Administration , Hospital Of The University Pennsylvania , Katharine Bar , Assistant Professor , Infectious Diseases , Talk Radio , 105 9 , 1059 , 105 7 , 1057 , 570 , Knrs , 570 Knrs , Glenn Beck , Utah Radio , Rush Limbaugh , Salt Lake City , Utah , 105 9 Knrs , Sean Hannity , ஒன்றுபட்டது மாநிலங்களில் , மருத்துவமனை ஆஃப் தி பல்கலைக்கழகம் பென்சில்வேனியா , க்யாத்ரிந் மதுக்கூடம் , உதவியாளர் ப்ரொஃபெஸர் , தொற்று நோய்கள் , பேச்சு வானொலி , க்ளென் பெக் , உட்டா வானொலி , அவசரம் லிம்பாக் , உப்பு ஏரி நகரம் , உட்டா ,

© 2024 Vimarsana